Icecure Medical (ICCM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.39M
Last updated: Nov 17, 2026 at 11:03 AM ET
Icecure Medical (ICCM) Stock Forecast
Analysts expect Icecure Medical (ICCM) to earn -$4.61 per share in the fiscal year ending Dec 31, 2026, on revenue of $4.29M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 2 | 66.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 105.1%.
- Fiscal year ending Dec 31, 2026
- -$4.61
- EPS consensus, revenue $4.29M
- Fiscal year ending Dec 31, 2027
- -$3.44
- EPS consensus, revenue $8.80M
- Next report
- Nov 18, 2026
- Confirmed, before the open
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$4.61 | -$4.61 to -$4.61 | 1 | $4.29M | $4.22M to $4.37M | 2 |
| Dec 31, 2027 | -$3.44 | -$3.71 to -$3.00 | 3 | $8.80M | $6.86M to $12.46M | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.17 | -$1.42 to -$0.88 | 5 | $1.63M | $1.47M to $1.78M | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$4.76.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$4.61 | -$4.61 | -$4.61 | -$4.76 | -$4.76 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.44 | -$3.44 | -$3.44 | -$3.87 | -$3.87 | N/A |
Frequently Asked Questions About ICCM
What is the ICCM stock forecast?
Consensus analyst estimates put Icecure Medical's EPS at -$4.61 for the fiscal year ending Dec 31, 2026, on revenue of $4.29M. The consensus rating from 3 analysts is Buy.
How do analysts rate ICCM stock?
Of 3 analysts covering Icecure Medical, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ICCM next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$4.61, with estimates from -$4.61 to -$4.61 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.44, with estimates from -$3.71 to -$3.00 from 3 analysts.
What revenue do analysts expect from Icecure Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $4.29M, with estimates from $4.22M to $4.37M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $8.80M, with estimates from $6.86M to $12.46M.
How many analysts cover ICCM?
3 analysts rate Icecure Medical stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
ICCM pages: Overview, Earnings, Forecast, Financials, Competitors